Swimmer's Ear Gets New Drug

Finafloxacin otic suspension (Xtoro), manufactured by Alcon Laboratories, was okayed to treat the condition when caused by Pseudomonas aeruginosa and/or Staphylococcus aureus, according to an FDA statement. http://www.medpagetoday.com/PrimaryCare/GeneralPrimaryCare/49188?xid=nl_mpt_DHE_2014-12-18&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=ST&eun=g721819d0r&userid=721819&email=amydugan2%40gmail.com&mu_id=5883165&utm_term=Daily